BODY PHARM RETRATRUDE PEN 64MG

Retatrutide 64mg Research Pen is a peptide research product featuring retatrutide (LY3437943), an investigational triple receptor agonist that activates the GIP, GLP-1, and glucagon receptors. Retatrutide is currently being evaluated in clinical research programs investigating metabolic health, obesity, type 2 diabetes, and related cardiometabolic conditions.